Sunday, Oct 1, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | For Likes Of India Pfizer Is On Vax Version Requiring Simple Refrigeration

For likes of India, Pfizer is on vax version requiring simple refrigeration

Pfizer's mRNA technology-based vaccine has an efficacy of over 90 per cent with a double dose and 67 per cent with a single dose. It, however, requires minus 70 degrees Celsius, which does not match India's cold storage facilities.

By IANS
Updated On - 05:44 PM, Wed - 9 December 20
For likes of India, Pfizer is on vax version requiring simple refrigeration
whatsapp facebook twitter telegram

New Delhi: US Drugmaker Pfizer, which had recently sought emergency use authorization of its coronavirus vaccine in India and whose shot require storage at minus 70 degrees Celsius, has revealed that the company is working on a new formulation which will be able to avoid storage at extreme temperature and can be stored in simple refrigeration.

Pfizer’s mRNA technology-based vaccine has an efficacy of over 90 per cent with a double dose and 67 per cent with a single dose. It, however, requires minus 70 degrees Celsius, which does not match India’s cold storage facilities.

Clarifying on the issue, Albert Bourla, Pfizer’s Chief Executive Officer (CEO), said at a press conference organized by the International Federation of Pharmaceutical Manufacturers and Associations: “We are working on a new formulation that will be able to avoid minus 70-degree Celsius temperature and can be stored in simple refrigeration.”

Bourla made the comment when asked, “Are you working on versions of your vaccine that can be stored in less extreme temperature in countries like India?”

He, however, emphasized that the company is currently confident about their ability to distribute the product at minus 70-degree Celsius. Besides this, Bourla charted out a detailed logistical plan and tools to support vaccine storage, temperature monitoring, and transport.

The multinational biopharmaceutical company had sought approval for emergency use authorization of its vaccine candidate in India on December 6 after getting clearance in the UK and Bahrain.

A Subject Expert Committee will take decision in the coming weeks.

To allay the fear of public on the safety of the vaccine, the Chief Executive Officer said: “In this case, the vaccines were developed very fast. What I will tell them that we did not cut corners. We tested this vaccine with the exact same way that we are testing any vaccine. Because of the scrutiny, it was tested with even higher standards.”

On Tuesday, the Union Health Ministry informed that as many as eight Covid-19 vaccine candidates are under different stages of clinical trials which could be ready for authorization in near future. Besides Pfizer, Bharat Biotech and Serum Institute of India have recently sought emergency use authorization of their vaccine.

Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • Corona Virus Deaths
  • Coronavirus
  • Coronavirus in India
  • Coronavirus Latest Updates

Related News

  • Afghanistan embassy in India ceases operations from today onwards, cites lack of support

    Afghanistan embassy in India ceases operations from today onwards, cites lack of support

  • Mcap of five of top 10 most valued firms decline by Rs 62,586 cr; TCS, Infosys biggest laggards

    Mcap of five of top 10 most valued firms decline by Rs 62,586 cr; TCS, Infosys biggest laggards

  • PM Modi congratulates Mohamed Muizzu on election as Maldives president

    PM Modi congratulates Mohamed Muizzu on election as Maldives president

  • KTR releases documentary on Telangana martyrs

    KTR releases documentary on Telangana martyrs

  • FPIs turn net sellers after 6 months of investment; withdraw Rs 14,767 cr in Sep

    FPIs turn net sellers after 6 months of investment; withdraw Rs 14,767 cr in Sep

  • Raja Kumari takes ‘The Bridge World Tour’ from Hyderabad to LA

    Raja Kumari takes ‘The Bridge World Tour’ from Hyderabad to LA

Latest News

  • BSP chief Mayawati to hold meeting with party leaders today to discuss strategy for Lok Sabha polls

    5 mins ago
  • Mika removes tweet comparing Sukesh with Jacqueline’s picture with Van Damme

    11 mins ago
  • Rasika Dugal participates in beach cleanup drive post Ganpati visarjan

    25 mins ago
  • Disha Patani remembers Sushant Singh Rajput as ‘MS Dhoni’ turns seven

    26 mins ago
  • Innovative wearable sensor tracks glucose, body temperature through sweat

    41 mins ago
  • Commercial LPG prices increased by Rs 209

    44 mins ago
  • Asian Games: Aditi Ashok clinches historic silver in women’s golf

    50 mins ago
  • The song that changed Bhumi Pednekar’s life

    51 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam